Completed PHASE4 INTERVENTIONAL 2-arm NCT01078038

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III) (LONG-DES-III)

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III: Sirolimus vs. Everolimus-eluting Stent

Sponsor: CardioVascular Research Foundation, Korea

Conditions Coronary Artery Disease

Interventions Cypher Xience V

Updated 6 times since 2017 Last updated: Aug 7, 2012 Started: Jun 30, 2008 Primary completion: Jun 30, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Coronary Artery Disease and is currently completed. CardioVascular Research Foundation, Korea leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CardioVascular Research Foundation, Korea
Seung-Jung Park

Data source: CardioVascular Research Foundation, Korea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anyang, South Korea , Bucheon-si, South Korea , Busan, South Korea , Cheonan, South Korea , Cheongju-si, South Korea , Chuncheon, South Korea , Daejeon, South Korea , Gangneung, South Korea , Gwangju, South Korea , Gyongju, South Korea and 6 more locations